As of 2025-01-13, the Relative Valuation of Abbott Laboratories (ABT) is 128.82 USD. This relative valuation is based on P/E multiples. With the latest stock price at 113.19 USD, the upside of Abbott Laboratories based on Relative Valuation is 13.8%.
The range of the Relative Valuation is 115.00 - 149.20 USD.
| Range | Selected | |
| Trailing P/E multiples | 36.6x - 41.6x | 39.0x |
| Forward P/E multiples | 29.5x - 38.3x | 32.8x |
| Fair Price | 115.00 - 149.20 | 128.82 |
| Upside | 1.6% - 31.8% | 13.8% |
| Date | P/E |
| 2025-01-13 | 33.97 |
| 2025-01-10 | 33.78 |
| 2025-01-08 | 34.36 |
| 2025-01-07 | 34.11 |
| 2025-01-06 | 34.00 |
| 2025-01-03 | 34.24 |
| 2025-01-02 | 34.12 |
| 2024-12-31 | 34.02 |
| 2024-12-30 | 33.93 |
| 2024-12-27 | 34.58 |
| 2024-12-26 | 34.67 |
| 2024-12-24 | 34.51 |
| 2024-12-23 | 34.38 |
| 2024-12-20 | 34.36 |
| 2024-12-19 | 33.81 |
| 2024-12-18 | 33.66 |
| 2024-12-17 | 34.07 |
| 2024-12-16 | 33.87 |
| 2024-12-13 | 34.10 |
| 2024-12-12 | 34.24 |
| 2024-12-11 | 34.33 |
| 2024-12-10 | 34.74 |
| 2024-12-09 | 34.56 |
| 2024-12-06 | 34.77 |
| 2024-12-05 | 34.76 |
| 2024-12-04 | 34.88 |
| 2024-12-03 | 34.97 |
| 2024-12-02 | 35.13 |
| 2024-11-29 | 35.72 |
| 2024-11-27 | 35.77 |
| 2024-11-26 | 35.48 |
| 2024-11-25 | 35.53 |
| 2024-11-22 | 35.42 |
| 2024-11-21 | 35.27 |
| 2024-11-20 | 34.87 |
| 2024-11-19 | 35.23 |
| 2024-11-18 | 35.30 |
| 2024-11-15 | 34.86 |
| 2024-11-14 | 34.60 |
| 2024-11-13 | 34.81 |
| 2024-11-12 | 35.02 |
| 2024-11-11 | 35.13 |
| 2024-11-08 | 35.07 |
| 2024-11-07 | 34.68 |
| 2024-11-06 | 35.13 |
| 2024-11-05 | 35.41 |
| 2024-11-04 | 35.38 |
| 2024-11-01 | 35.67 |
| 2024-10-31 | 34.10 |
| 2024-10-30 | 34.42 |